Study of toric intraocular lens (IOL) versus limbal relaxing incisions in the management of cataract astigmatism

ISRCTN ISRCTN24411195
DOI https://doi.org/10.1186/ISRCTN24411195
Secondary identifying numbers 13/SC/0050
Submission date
12/04/2013
Registration date
15/05/2013
Last edited
18/05/2017
Recruitment status
Stopped
Overall study status
Stopped
Condition category
Eye Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English Summary

Background and study aims
The quality of vision following cataract surgery is affected by the clarity of the ocular media (transparent substances of the eye, i.e the cornea, intraocular lens [IOL], lens capsule and vitreous gel), focus (corneal curvature and IOL) and co-morbidity, e.g. retinal or optic nerve disease. One aspect of focussing is astigmatism, where the vision is blurred due to the inability of the optics of the eye to focus a point object into a sharp focused image on the retina, and is caused in cataract post-surgical patients by asymmetry of corneal curvature. This study aims to assess the effect of two alternative means of correcting astigmatism to optimise focus. The first is the placement of additional corneal incisions to directly reduce corneal astigmatism and second is the use of toric IOLs which may alternatively be used to compensate for corneal astigmatism.

Who can participate?
Males and females aged over 18 years listed for cataract surgery.

What does the study involve?
The participants are randomly allocated to one of two groups:
Group 1: Corneal Limbal Relaxing Incisions (LRIs). These are paired partial-thickness incisions placed just within the cornea immediately prior to small incision cataract surgery. This technique corrects up to 3D of cylinder, which is the maximum level correctable on the inclusion criteria.
Group 2: IOL. The Tecnis toric IOL is implanted during cataract surgery to correct astigmatism.
The study will be conducted in compliance with the protocol, Good Clinical Practice, and all applicable regulatory requirements.

What are the possible benefits and risks of participating?
The study intervention is a choice between two alternative means of reducing post-operative astigmatism. Additional surgical incisions carry a risk of infection, reduced by the routine use of post-operative antibiotic eyedrops. The corneal incisions may also in the immediate post-operative period give a foreign body sensation in the eye. Toric IOLs may rotate in the eye; if rotation is excessive then surgical repositioning may be required. Both techniques carry the risk of over- or under-correcting astigmatism, such that spectacle correction of vision remains necessary.

Where is the study run from?
Royal Berkshire NHS Foundation Trust (UK).

When is the study starting and how long is it expected to run for?
May 2013 to January 2014

Who is funding the study?
Abbott Medical Optics Inc. (USA)

Who is the main contact?
Mr Martin Leyland

Contact information

Mr Martin Leyland
Scientific

Royal Berkshire NHS Foundation Trust
London Road
Reading
RG1 5AN
United Kingdom

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details to request a patient information sheet
Scientific titleRandomised controlled trial of Tecnis 1-piece toric intraocular lens (IOL) versus limbal relaxing incisions in the management of cataract astigmatism
Study hypothesisToric IOLs may be an effective alternative to limbal relaxing incisions (LRIs) for the treatment of astigmatism post cataract surgery.
Ethics approval(s)Berkshire South Central NRES Committee, 05/03/2013, ref: 13/SC/0050
ConditionCataract surgery
InterventionReducing astigmatism by comparing toric IOLs vs limbal relaxing incisions (LRIs). This study is a randomised controlled trial of two techniques to control post-operative astigmatism.

Group 1: Corneal Limbal Relaxing Incisions (LRIs). These are paired partial thickness incisions placed just within the cornea immediately prior to small incision cataract surgery. This technique corrects up to 3D of cylinder, which is the maximum level correctable on the inclusion criteria.

Group 2: IOL. The Tecnis toric IOL is can be implanted during cataract surgery to correct astigmatism, and is available in cylindrical powers of 1.00, 1.5, 2.25, 3.00 and 4.00 with a spherical diopter range of 5-34 dioptres. Toric IOL biometry calculations using a proprietary algorithm (AMO Abbott Medical Optical), cross-referenced with standard biometry calculation.

The study will be conducted in compliance with the protocol, Good Clinical Practice, and all applicable regulatory requirements.
Intervention typeProcedure/Surgery
Primary outcome measure1. Visual acuity
2. Corneal astigmatism

Unaided vision will be measured 2 weeks after the operation
Optician sight test will be carried out 6 weeks after the operation
Secondary outcome measuresVisual satisfaction score will be measured 6 weeks after the operation
Overall study start date01/05/2013
Overall study end date01/01/2014
Reason abandoned (if study stopped)Participant recruitment issue

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants40
Participant inclusion criteria1. Symptomatic cataract
2. Vision 6/12 or worse
3. Corneal astigmatism >0.75D horizontal or >1.25D vertical and (maximum 3.0D)
4. Males and females aged over 18 years
Participant exclusion criteria1. <18 years of age
2. Astigmatism >3.0D or irregular
3. Dry eye severe enough to affect keratometry despite topical lubricant treatment
4. Ocular co-morbidity
Recruitment start date01/05/2013
Recruitment end date01/01/2014

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Royal Berkshire NHS Foundation Trust
Reading
RG1 5AN
United Kingdom

Sponsor information

Royal Berkshire NHS Foundation Trust (UK)
Hospital/treatment centre

London Road
Reading
RG1 5AN
England
United Kingdom

Website http://www.royalberkshire.nhs.uk
ROR logo "ROR" https://ror.org/034nvrd87

Funders

Funder type

Industry

Abbott Medical Optics Inc. (USA) will provide the toric IOL at the same price as the non-toric IOL

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
HRA research summary 28/06/2023 No No

Editorial Notes

18/05/2017: The trial was stopped due to poor recruitment.